Skip to product information
1 of 2

International Myeloma Foundation

IMF Publication - Understanding Ninlaro®(ixazomib) capsules

IMF Publication - Understanding Ninlaro®(ixazomib) capsules

Regular price $0.00 USD
Regular price Sale price $0.00 USD
Sale Sold out
Shipping calculated at checkout.

Ninlaro® (ixazomib) is the first oral proteasome inhibitor approved by the FDA to treat myeloma. Ninlaro is the third drug in the proteasome inhibitor class that has been approved for myeloma. It is indicated for myeloma patients who have received at least one prior therapy. You can also download a copy here: https://www.myeloma.org/resource-library/understanding-ninlaro

View full details
  • Shipping Information

    FREE SHIPPING for all tip cards and publications.

    Shipping times typically take 7-14 business days. Orders totaling up to $49.99 will incur a shipping cost of $5; orders totaling $50 and up will incur a shipping cost of $10.

    Currently, the IMF does not provide international shipping via our Shopify store. If you are planning to purchase IMF merchandise or to order free educational publications outside of the U.S. (including U.S. territories), please contact the IMF directly at the imf@myeloma.org or 1-818-487-7455.